13 April 2020 - Reliance on the private market to develop vaccines has failed, leaving us vulnerable to pandemics such as COVID-19, public health experts say.

Vaccines are far more expensive to develop and produce than other drugs, and many of the potential customers are the global poor, making big pharma companies reluctant to invest.

Nobel laureate and immunologist Professor Peter Doherty said the world needed to change its funding model for vaccine development.

Read The Age article